These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1926435)

  • 1. Hormonal response to brain death.
    Sazontseva IE; Kozlov IA; Moisuc YG; Ermolenko AE; Afonin VV; Ilnitskiy VV
    Transplant Proc; 1991 Oct; 23(5):2467. PubMed ID: 1926435
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal alteration and pituitary function during course of brain-stem death in potential organ donors.
    Harms J; Isemer FE; Kolenda H
    Transplant Proc; 1991 Oct; 23(5):2614-6. PubMed ID: 1926503
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone levels, hemodynamics, and metabolism in brain dead organ donors.
    Mariot J; Sadoune LO; Jacob F; Dousset B; Perrier JF; Jacob C; Strub P; Voltz C
    Transplant Proc; 1995 Feb; 27(1):793-4. PubMed ID: 7879187
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hormone evaluation in brain death].
    Gravame V; Porretti L; Cardillo M; Marchesi G; Rizzi M; Sacchi C; Candiani A; Chiaranda M; Gualandris L; Taioli E; Scalamogna M
    Minerva Anestesiol; 1999 Oct; 65(10):725-31. PubMed ID: 10598430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The physiopathological and therapeutic implications of the hormonal disorders associated with brain death].
    Amado JA; Diago MC; García-Unzueta MT; López-Espadas F
    Rev Clin Esp; 1997 Jan; 197(1):35-41. PubMed ID: 9102670
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain death effects on catecholamine levels and subsequent cardiac damage assessed in organ donors.
    Pérez López S; Otero Hernández J; Vázquez Moreno N; Escudero Augusto D; Alvarez Menéndez F; Astudillo González A
    J Heart Lung Transplant; 2009 Aug; 28(8):815-20. PubMed ID: 19632578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monitoring of mixed venous oxygen saturation in multiorgan donors. Preliminary data].
    Dauri M; Turani F; Andreozzi G; Celeste GF; Colella DF; Zupancich E; Leonardis F; Giovannini C; Sabato AF
    Minerva Anestesiol; 1991 Dec; 57(12 Suppl):139-46. PubMed ID: 1806822
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormonal resuscitation therapy in the management of the brain-dead potential organ donor.
    Cooper DK
    Int J Surg; 2008 Feb; 6(1):3-4. PubMed ID: 18359462
    [No Abstract]   [Full Text] [Related]  

  • 9. Stable myocardial function and endocrine dysfunction during experimental brain death.
    Ferrera R; Ovize M; Claustrat B; Hadour G
    J Heart Lung Transplant; 2005 Jul; 24(7):921-7. PubMed ID: 15982623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A valid experimental brain death organ donor model.
    Bittner HB; Kendall SW; Campbell KA; Montine TJ; Van Trigt P
    J Heart Lung Transplant; 1995; 14(2):308-17. PubMed ID: 7779850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic changes during brain stem death--lessons for management of the organ donor.
    Smith M
    J Heart Lung Transplant; 2004 Sep; 23(9 Suppl):S217-22. PubMed ID: 15381167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative hemodynamic heterogeneity of brain dead organ donors.
    Duke PK; Ramsay MA; Paulsen AW; Gunning TC; Roberts LC; Swygert TH; Valek TR
    Transplant Proc; 1991 Oct; 23(5):2485-6. PubMed ID: 1926444
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic inflammation in the brain-dead organ donor.
    Barklin A
    Acta Anaesthesiol Scand; 2009 Apr; 53(4):425-35. PubMed ID: 19226294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal resuscitation yields more transplanted hearts, with improved early function.
    Rosendale JD; Kauffman HM; McBride MA; Chabalewski FL; Zaroff JG; Garrity ER; Delmonico FL; Rosengard BR
    Transplantation; 2003 Apr; 75(8):1336-41. PubMed ID: 12717226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of decreased cortisol reserve in brain-dead potential organ donors.
    Dimopoulou I; Tsagarakis S; Anthi A; Milou E; Ilias I; Stavrakaki K; Charalambidis C; Tzanela M; Orfanos S; Mandragos K; Thalassinos N; Roussos C
    Crit Care Med; 2003 Apr; 31(4):1113-7. PubMed ID: 12682481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoalbuminaemia in brain-dead donors for liver transplantation.
    Ibirogba SB; Spearman CW; Mall A; Shepherd E; Kahn D
    S Afr J Surg; 2005 Aug; 43(3):66-8. PubMed ID: 16180389
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of hormonal supplements on the maintenance of cardiac function in potential donor patients after cerebral death.
    Taniguchi S; Kitamura S; Kawachi K; Doi Y; Aoyama N
    Eur J Cardiothorac Surg; 1992; 6(2):96-101; discussion 102. PubMed ID: 1581088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and oxygen transport patterns after head trauma and brain death: implications for management of the organ donor.
    Belzberg H; Shoemaker WC; Wo CC; Nicholls TP; Dang AB; Zelman V; Gruen JP; Berne TV; Demetriades D
    J Trauma; 2007 Nov; 63(5):1032-42. PubMed ID: 17993948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic and hydroelectrolytic problems in the care of potential multiorgan donors].
    Malacarne P; Casagli S; Cellai F; Di Sacco I
    Minerva Chir; 1995 Mar; 50(3):269-74. PubMed ID: 7659263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the brain death related endocrine dysfunction an indication for hormonal substitution therapy in the early period ?
    Hagl C; Szabó G; Sebening C; Tochtermann U; Vahl CF; Sonnenberg K; Hagl S
    Eur J Med Res; 1997 Oct; 2(10):437-40. PubMed ID: 9348271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.